Evidence map›Paper›PMID 37837098›Full record

ArticleSensors (Basel, Switzerland)2023

Comparative Analysis of Predictive Interstitial Glucose Level Classification Models.

Svjatoslavs Kistkins, Timurs Mihailovs, Sergejs Lobanovs, Valdis Pīrāgs, Harald Sourij, Othmar Moser, Dmitrijs Bļizņuks

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Svjatoslavs KistkinsResearch Institute of Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.
Timurs MihailovsInstitute of Smart Computing Technologies, Riga Technical University, LV-1048 Riga, Latvia.
Sergejs LobanovsResearch Institute of Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.ORCID 0009-0007-9896-0817
Valdis PīrāgsResearch Institute of Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.
Harald SourijInterdisciplinary Metabolic Medicine Trials Unit, Division of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-3510-9594
Othmar MoserDivision of Exercise Physiology and Metabolism, Institute of Sport Science, University of Bayreuth, 95447 Bayreuth, Germany.
Dmitrijs BļizņuksInstitute of Smart Computing Technologies, Riga Technical University, LV-1048 Riga, Latvia.ORCID 0000-0003-4252-9220
Pauls Stradiņš Clinical University Hospital · LVRiga Technical University · LVMedical University of Graz · ATUniversity of Bayreuth · DE

Funding

Latvian Council of Science No. VPP-EM-BIOMEDICĪNA-2022/1-0001
6 · The paper itself

Abstract

backgroundNew methods of continuous glucose monitoring (CGM) provide real-time alerts for hypoglycemia, hyperglycemia, and rapid fluctuations of glucose levels, thereby improving glycemic control, which is especially crucial during meals and physical activity. However, complex CGM systems pose challenges for individuals with diabetes and healthcare professionals, particularly when interpreting rapid glucose level changes, dealing with sensor delays (approximately a 10 min difference between interstitial and plasma glucose readings), and addressing potential malfunctions. The development of advanced predictive glucose level classification models becomes imperative for optimizing insulin dosing and managing daily activities.

methodsThe aim of this study was to investigate the efficacy of three different predictive models for the glucose level classification: (1) an autoregressive integrated moving average model (ARIMA), (2) logistic regression, and (3) long short-term memory networks (LSTM). The performance of these models was evaluated in predicting hypoglycemia (<70 mg/dL), euglycemia (70-180 mg/dL), and hyperglycemia (>180 mg/dL) classes 15 min and 1 h ahead. More specifically, the confusion matrices were obtained and metrics such as precision, recall, and accuracy were computed for each model at each predictive horizon.

resultsAs expected, ARIMA underperformed the other models in predicting hyper- and hypoglycemia classes for both the 15 min and 1 h horizons. For the 15 min forecast horizon, the performance of logistic regression was the highest of all the models for all glycemia classes, with recall rates of 96% for hyper, 91% for norm, and 98% for hypoglycemia. For the 1 h forecast horizon, the LSTM model turned out to be the best for hyper- and hypoglycemia classes, achieving recall values of 85% and 87% respectively.

conclusionsOur findings suggest that different models may have varying strengths and weaknesses in predicting glucose level classes, and the choice of model should be carefully considered based on the specific requirements and context of the clinical application. The logistic regression model proved to be more accurate for the next 15 min, particularly in predicting hypoglycemia. However, the LSTM model outperformed logistic regression in predicting glucose level class for the next hour. Future research could explore hybrid models or ensemble approaches that combine the strengths of multiple models to further enhance the accuracy and reliability of glucose predictions.

Indexed as

HyperglycemiaHypoglycemiaAlgorithmsBlood GlucoseBlood Glucose Self-MonitoringGlucoseHumansHypoglycemic AgentsInsulinReproducibility of ResultsBlood GlucoseGlucoseHypoglycemic AgentsInsulinARIMACGMdiabeteshyperglycemiahypoglycemialogistic regressionLSTMprediction

Identifiers

PMID37837098
PMCPMC10574913
OpenAlexW4387400406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.